Is Ovid Therapeutics Inc. overvalued?

Ovid Therapeutics Inc. (OVID) — key valuation metrics and fundamentals.

No verdict

Price

$2.54

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$479.4M

Dividend yield

0.0%

Return on equity

-23.4%

Sector

Healthcare

Fair value compares OVID's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.

Related stocks